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Abstract 
Nanostructures are emerging as a promising drug delivery paradigm, revolutionizing areas of 
non-invasive medicine in diagnosis, imaging and treatment of diseases. The use of nanoparticles 
enhances the uptake of the drug by appropriate cells, which make nanotubes an ideal structure 
for orally delivered drugs. Effective delivery of targeted drug molecules and economic 
production are fundamental to the material selection.  Alginate nanotubes combine the 
therapeutic effects of alginates as natural polyacids, which in the presence of ions form pH-
sensitive gels with reswell abilities and the uptake efficiency of nanostructures. Alginates have 
been widely used in the food industry as thickening agents due to their non-toxicity, as tissue 
membranes and as drug carriers in pharmaceutical research. The biocompatibility and relatively 
low cost of alginates, together with an easy method for fabrication make alginates the perfect 
polymer as a drug carrier. In the present study, a template-assisted technique was used to 
fabricate cross-linked sodium alginate and calcium chloride (SA-CaCl2) gel nanotubes using 
commercial anodized aluminum oxide (AAO) templates. After dissolution of the template, the 
nanotubes were characterized in Scanning electron microscope (SEM) to analyze the effects of 
dipping cycle, dipping time, concentration of Sodium Alginate and concentration of Ca2+ ions on 
the morphology of the tubes. The typical diameter, length and thickness of tubes are on the order 
of 200-300nm, 10-30µm and 60-75nm respectively. Optimum concentration of alginate to 
produce distinct fully formed nanotubes was of the order of 1wt% and template dipping time of 
less than 4h. The implications of this economical methodology of producing 1D drug carriers 
could possibly reduce drug side effects and alleviate the commercialization process in the 
development of new drugs in the Pharmaceutical field. The applications of this non-toxic stimuli-
responsive carrier are already being used in Molecular Gastronomy and could be applied in 
Precision Farming. 
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1. OBJECTIVES 
 
The major objectives of this project were: 
1. To explore the unprecedented impact nanoparticles are having in the areas of medical 
research in medicine and drug delivery 
 
2. Survey a range of biocompatible and biodegradable materials to use as drug carrier 
that can be ingested with minimal side effects and be economically viable for 
potential commercialization 
 
3. To evaluate the use of simple commercial materials such as Sodium Alginate in novel 
biomedical applications and survey a range of fabrication methods for producing 1D 
nanostructures 
 
4. To narrow the number of variables to only dipping time of the template, times of 
dipping of the template into calcium chloride, concentration of sodium Alginate and 
concentration of calcium chloride 
 
5. To set up the optimum methodology in terms of order of dipping the template  
 
6. To characterize the nanotubes under the SEM depending on the variables and find 
range of conditions to fabricate nanotubes of acceptable length 
 
7. To obtain the optimum conditions for stable nanotubes with appropriate thickness  
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2. INTRODUCTION 
 
 
Nanotechnology is said to have brought a new era with unlimited applications, opening doors to new 
branches of academia and research today. Although many nano applications are still promises, many 
of them could potentially change the way we live our lives in applications such as Mechanical 
nanosensors with possible use as cantilever piezoresistive sensors to measure fluid viscosity in 
monitoring abnormal cells in biometrics and even in drinking water1. In the photography, Single-
carrier Modulation Photodetector (SMPD) will apparently render flash photography obsolete since 
those SMPD sensors will be 2000 times more light-sensitive than traditional Complementary Metal 
Oxide Semiconductor (CMOS) which will eliminate the need for flash during photography 2. Other 
potential sensors already in use in the human body to detect cancer cells are gold nanoparticles3 and 
potentially carbon nanotubes which give more conclusive X-rays, CT and MRI images 2. The 
applications of nanoparticles and nanostructures are much wider than this and are increasing with the 
extent of other technological breakthroughs.  
 
Among the most prominent areas of medical research today is the design of drug delivery at the 
specific location and at the right dosage to reduce side effects. Researches carried out on nanocarriers 
have shown that these nanostructures minimize and can prevent drug degradation as well as cellular 
efflux 4. Drug release is also of concern when considering a polymer as drug carrier since the time 
and dosage of drug released are crucial for the proper functioning of most drugs 5. Polymeric 
nanoparticles have shown great promise as potential oral delivery systems especially for vaccines, as 
they protect encapsulated substances and are able to modify physicochemical characteristics, drug 
release and biological behavior 6. The potential success of these particles in the clinic relies on 
consideration of important parameters such as nanostructure fabrication strategies, their physical 
10 
 
properties, drug loading efficiencies, drug release potential, and, most importantly, minimum toxicity 
of the carrier itself. 
 
Sodium Alginates (SA) is a natural polyanionic linear co-polymer of 1,4-linked guluronic acid and 
mannuronic acid residues obtained from Brown algae 7. In the presence of multivalent cations such as 
aqueous Ca2+, the Ca2+/COO- linkage forms a solid gel which is sensitive to pH, making the drug-
infiltrated SA-CaCl2 nanotubes resistance to gastric acids in the stomach and a good drug carrier to 
the intestine and colon 8. Due to their pH-sensitivity with the ability to swell at certain pH 9, alginates 
have been of great interest for drug release, in addition to their biodegradability and biocompatibility 
10. Among the materials published on biological applications of alginates are assembled SA/Chitosan 
nanotubes 10 and SA/CNT 11 to help in drug delivery and minimize drug leakage 12. However the 
toxicity of CNT 13 and chitosan 14 remain questionable. 
 
Economical mode of production is also fundamental in the commercialization of any drug. Successful 
formation of nanotubes by the template-assisted dipping technique has been reported with 
polystyrene-tetradrofuran solutions 15. In this project, a modified template-assisted technique as 
reported, was used to fabricate crosslinked SA and CaCl2 nanotubes for the formation of stable 
nanostructures. To this end, the dipping cycles, dipping times, concentration of SA and concentration 
of CaCl2 were investigated to find the optimum conditions for stable crosslinked SA-CaCl2 nanotubes 
by this method. SEM was used to characterize the morphology of the nanotubes, that is their length 
and diameter size, which is related to the four variables identified above.  
 
However, the control of morphology and size of the nanoshapes formed remains a challenge since 
under high concentration of CaCl2, the nanotubes gel formed were either distorted shapes or rods. The 
nanostructures formed under low concentration of SA collapsed upon drying so that possible 
11 
 
nanotubes formed could not be identified via SEM. The correct conditions produced strong enough 
tubes which did not collapse upon drying and had acceptable length in µm range. 
 
This template-infiltrated method of producing nanotubes offered one of the most convenient, cheapest 
and generic procedure for fabricating nanotubes compared to electropolymerization and molecular 
self-assembly processes of synthesizing 1D nanostructures 16. If successfully commercialized, the 
crosslinked SA-CaCl2 nanotubes may improve drastically the effectiveness of drugs with decreased 
side effects. Other potential applications of these crosslinked SA-CaCl2 nanotubes as drug carriers 
could also extend to any kind of carrier for example to enhance flavor 17 by entrapping the flavor 
ingredients in nanocarriers that releases the flavor or color upon external stimuli like pH, water or 
heat. In analogy to the use of nanocarriers to deliver drugs in the human body, nanocarriers could 
similarly be able to respond to different soil or weather environments to deliver pesticides/ herbicides 
in a controlled and targeted manner 18.  
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3. NANOTECHNOLOGY IN MEDICINE  
 
 
Nanotechnology has redefined and is still redefining certain areas of medicine in terms of diagnosis, 
imaging and treatment. Nanostructures have become a highly researched topic in the areas of 
biomedical and drug delivery. The prospects of nanoparticles for therapeutic and diagnostic tools 
have high-rocketed in the past decade with research on nanoparticles as biosensors in diagnosing 
cancer cells 2, as enhanced MRI contrasting agents 19, as engineered magnetic nanoparticles in 
theranostics 20, as receptor-targeted peptide for better efficacy for therapeutic anti-cancer molecules 3 
and as multifunctional nanoparticles for smart drug delivery system 21.  
 
Recent social science analyses suggest that in some cases, “bio-sensationalism” could be a relieving 
platform for the establishment of biotechnologies 22. Furthermore, easing the path for exploratory 
technologies will likely impact on the regulation and economic promise of pharmaceuticals which are 
targeting not only therapeutic but diagnostic effects.  In addition to the economic promise in 
diagnosing diseases, nanoparticles have shown great prospect in improving the drug delivery system 
with localized drug carriers that might revolutionize medical treatment processes 22. Targeting 
specific organs of the human body might have great implications in terms of drug intake quantity and 
efficiency in recovery time for patients while reducing side effects as well as providing a positive 
financial boost for pharmaceutical companies. Needless to say that direct and rapid analysis of 
diseases and effective treatment by oral administration could impact humankind in unprecedented 
ways.  
 
As presented in this section, nanotechnology has upgraded medicine in various ways from diagnosis 
to imaging to medical treatment by increasing the reactive surface area of particles (Fig. 1). This 
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project will focus more on the use of nanoparticles in medical treatment and more specifically 
nanoparticles as drug carriers via orally-administered drug intake discussed in the following chapters. 
 
 
Figure 1. Nanocrystal Particles absorbed with surface stabilizers 23 
 
 
 
3.1. Nanosensors 
 
 
Detecting biological and chemical species is crucial in diagnosing diseases and nanostructures in 
the form of nanowires offer exceptional electrical and optical properties that can be used for 
sensing 2.  In short, these inorganic nanowires made of silicon can act as field-effect devices 
(FET) with modified specific surface receptors to detect viruses and drug discovery. 
 
By binding specifically to proteins, organic molecules are the major sources to the discovery and 
development of new drugs which is why special sensors are needed.  An example of this process 
is the identification of molecular inhibitors to tyrosine kinases 2. By definition, tyrosine kinases 
are proteins that mediate signal transduction in mammalian cells through phosphorylation of a 
tyrosine residue of a substrate protein using adenonsine triphosphate (ATP). Deregulation of the 
14 
 
phosphorylation process has been linked to various diseases including cancer. By measuring the 
conductance between the silicon nanowire surface, more rapid, direct and high-sensitivity data 
can obtained compared to existing methods 2. 
 
The extreme sensitivity of the nanowire FET (Field-effect transmission) was put to test by recent 
studies in the detection of viruses, which are an increasing concern as agents for biological 
warfare and terrorism 24. The concept is that when a virus particle binds and unbinds to an 
antibody receptor on a nanowire device, the conductance of the nanowire sensor will change. For 
example, experiments carried out with highly dilute influenza A virus solutions produced well-
defined discrete conductance changes. The data can be further enhanced from simultaneous 
optical and electrical measurements using fluorescently labeled influenza viruses 2. This 
quantized optimization of detecting viruses opens up possibilities of developing ultradense 
nanowire device arrays without crosstalk in the future and where virus attacks could be mitigated 
or prevented by immediate detection. 
 
 
3.2. Theranostics/theragnostics Agents 
 
 
“Theranostics” or sometimes called “theragnostics” was coined by developing more personalized 
therapies for various diseases synthesizing both diagnostic and therapeutic capabilities. Existing 
cancer treatments for example target only limited patients at specific stages of the disease 
development. The goal behind theranostics was to hopefully tailor individualized treatments 
based on reactions to new medication and improve prognoses 20. Nanoparticle (NP)-based 
imaging and therapy have been investigated separately, nanoparticles as theranostic agents and 
nanoparticles as imaging agents but since most nanoparticles are imaging agents, the can be 
readily transformed into theranostic agents by loading therapeutic functions on them. The 
15 
 
unprecedented advantage is that imaging can be performed not only before and after but also 
during treatment 15. However, nanoparticle-based imaging and therapy are each struggling to 
advance into clinical trials and thus nanoparticle- based theranostics are still in their embryonic 
stages of development 20.  
 
3.2.1. Nanoparticle-based theranostic agents  
Thorough positive research on nanoparticle as imaging agents have been carried out on 
Iron oxide nanoparticles, quantum dots, carbon nanotubes (CNTs), gold nanoparticles 
and silica nanoparticles, which are also being considered as potential candidate for 
building up nanoparticle-based theranostics 25. Each nanoparticles has its own benefits 
and disadvantages which include the superior magnetic properties of Iron oxide 
nanoparticles against their intrinsic low sensitivity as MRI contrast probes, the bright 
photo-chemically stable Quantum dots against their toxicity, the high transfection 
efficiency of CNTs against their non-biodegradable nature, the easily manipulated gold 
nanoparticles against their exorbitant cost, and the easy drug intake of silica nanoparticles 
against their oversized particles 25. As drug carriers, specific targeting is of the ultimate 
goal as researchers are trying to introduce a targeting motif onto nanoplatforms to 
achieve an improved targeting profile. On the other hand, studies are also being carried 
out using nanoparticle-based hyperthermia, where treatment only occurs in a confined 
region and allows minimal normal tissue damage 25. Until proper and safe clinical 
standards are met, nanoparticles used in theranostics will remain in their trial stages. 
 
Research carried out by Janib et al. have investigated major classes of potential 
theranostic nanoparticles such as drug conjugates and complexes, dendrimers, vesicles, 
micelles, core–shell particles, microbubbles, and carbon nanotubes as carriers of either 
drugs or contrast agents as compared to regular optically active small molecules, metals 
16 
 
and metal oxides, ultrasonic contrast agents, and radionuclides found in existing methods 
of imaging (optical imaging, computed topography, Magnetic Resonance Imaging, 
Gamma Scintigraphy and ultrasound) 19. The benefits and disadvantages of existing 
imaging devices are given in Table 1. In the study, theranostic nanoparticles as 
mentioned are discussed thoroughly as to their drug-loading efficiency and imaging 
capabilities based on their interaction with their surrounding environments. With 
enhanced drug loading capacity, dendrimers for example have proved to be a good MRI 
and CT contrasting agent, eliminating some of the problems arising from regular 
methods19. 
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Table 1. Summary of the properties and characteristics imaging modalities 19 
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3.2.2. Magnetic nanoparticles for theranostics 
 
Magnetic nanoparticles (MNPs) are an emerging class of nanoparticles that can be 
manipulated under the influence of an external magnetic field. MNPs are commonly 
composed of magnetic elements, such as iron, nickel, cobalt and their oxides.  The 
simultaneous functionalization and control by a magnetic field have propelled MNPs 
towards advanced magnetic resonance imaging (MRI), guided drug and gene delivery, 
magnetic hyperthermia cancer therapy (selective localized heating of the tumor cells 
using magnetic nanoparticles to kill the tumor cells by necrosis if temperature is above 
43℃ for about 30 minutes 20), tissue engineering and cell tracking. Integrative 
theranostic applications have emerged with MNP use, such as MRI-guided cell 
replacement therapy or MRI-based imaging of cancer-specific gene delivery 20. 
Controlling the shapes of MNPs influences the function and magnetic properties in 
biological systems such as in vivo circulation time and effective tumor targeting 20. 
Clinical preparations of MNPs have traditionally relied upon organic biodegradable 
dextran and carbohydrate derivatives because of their high affinity to iron oxides but 
those are unstable at high temperatures and are not suitable to protect reactive MNPs 20. 
This dilemma has limited the use for more complex integrative applications of MNPs in 
imaging. 
 
However, data shows that certain properties of nanoparticles such as enhanced reactive 
area, ability to cross cell and tissue barriers and resistance to biodegradation, tend to 
amplify their cytotoxic potential relative to molecular or bulk counterparts 20. This 
means that by enhancing imaging of cancer cells for example, using MNPs as imaging 
agents could increase or aggravate the disease or cause other health issues.   
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3.3. Drug delivery 
 
Figure 2. Important parameters for the design of drug delivery carriers 26.  
 
 
With the advent of nanotechnology, nanoparticles in drug delivery have brought exciting news 
with possibility of decreased side effects and prolonged drug exposure due to drug slow release. 
For example, the resistance of many microorganisms to antibiotics is often related to low uptake 
of antibiotics or reduced activity in acidic pH of lysosomes 27. Another example of the benefits of 
nanoparticles in medicine is the use of ampicillin-loaded nanospheres for Listeria treatment. A 
dramatic improvement was observed over the release of the drug as bacterial counts in liver were 
reduced at least 20-fold 27. Similarly, with Ampicillin-loaded nanospheres for Salmonella 
treatment, 32 mg per mouse was required with the drug alone and only 0.8 mg ensured was 
needed with the nanoparticles to ensure survival 27. 
 
If a drug is cleared too quickly from the body, this would require a patient to use high doses while 
with slow drug delivery systems, clearance of the drug from the circulation can be reduced by 
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altering the pharmacokinetics of the drug. Additionally, a higher dose of drug may cause tissue 
damage, but with drug delivery, regulated drug release can eliminate this problem. Therefore it is 
fundamental to study the sizes, shapes, Mechanical properties, Surface texture and compartment 
(Fig. 2) of these nanoparticles as these are what will determine their functions and relevance as 
drug carriers. 
 
Polymeric nanoparticles as drug carriers targeting lower body parts have a special place from the 
pharmaceutical point of view since they are more stable in the gastrointestinal tract than other 
colloidal carriers and can protect encapsulated drugs. Polymers are very large molecules 
composed of repeating structural units connected by covalent chemical bonds. Due to reswell 
(ability to swell or expand depending on various environments such as pH value) and 
hydrophobicity (non-polar molecules) properties, some polymeric materials have shown good 
drug-release properties and biocompatibility 12. 
 
Polymeric materials used for the formulation of nanoparticles include synthetic polymers such as 
(poly(lactic acids) (PLA), poly(lactic-coglycolic acids) (PLGA), poly(ε-caprolactone) (PCL), 
poly(methyl methacrylates), and poly(alkyl cyanoacrylates)) or natural polymers (albumin, 
gelatin, alginate, collagen or chitosan) 12. Polyesters, alone and in combination with other 
polymers, are the most commonly used for the formulation of nanoparticles. PLGA and PLA are 
highly biocompatible and biodegradable polymers having been used since for numerous in vivo 
applications such as biodegradable implants and controlled drug release 12. Further discussion on 
the choice of drug carrier will be developed in the next chapter. 
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3.4. Smart, stimuli sensitive multifunctional nanoparticles 
 
 
The use of smart stimuli sensitive multifunctional nanoparticles are nanosystems that have been 
engineered to respond in a predictable way depending on the stimuli. For example, the pH-
responsive hydrophilic polymer, chitosan, has been extensively investigated as a delivery system 
for therapeutic drugs 28, and proteins 29, and has been proven to form a long-circulating drug 
delivery system in vivo. In the study by Li et al., magnetic hollow spheres coated with 
biodegradable pH-sensitive polymers (chitosan) have been used as a smart drug delivery system, 
which can be manipulated by an external magnetic field 21. By incorporating fluorescent 
semiconductor quantum dots into the chitosan composite, real time visualization of the drug 
delivery system when controllably releasing the drugs was possible 21. It was found that the cross-
linking of the chitosan nanoparticles with glutaraldehyde favors the swelling ability of the 
composite particles and also the drug release properties. It significantly optimized its mechanical 
properties, and decreased its surface positive charge, which are preferable for in vivo use 21. The 
final result was an effective drug delivery for systematic administration of a variety of 
pharmaceutical drugs and proteins, high encapsulation efficiency at 99% and loading of up to 
82% which allowed enhanced targeting of tumor-specific ligands 21. The external control via 
magnetic field provided an efficient and easy way of operation, eliminating the need for side-
effects and other problems associated with oral administered drug in the body. 
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4. DRUG DELIVERY 
 
 
When drugs are administered not all of the drugs are efficiently taken to the targeted receptors or 
sites of action. Most of the drug dose is washed away or taken up by wrong tissues. This is the 
reason behind the frantic search to find a more efficient route of transportation and minimize side 
effects of drugs. 
 
Encapsulation of the drug via an engineered orally-administered drug transport “mold” will be the 
target of our analysis while drug delivery methods by other means such inhalation, transdermal, 
implantation or injection are beyond the scope of this project. A brief summary of drug carriers 
systems and natural polymers as drug carriers will be presented in this section, followed by reasons 
for the best choice of material as drug scaffold in the next chapter. 
 
 
4.1. Drug discovery process 
 
 
Medical treatment has become a luxury with the rising cost of healthcare insurance in the US. In 
the quest for more effective, economical and rapid medical treatment, non-invasive drug intake is 
a feasible research area that has boosted pharmaceutical companies. In 2006, the United States 
accounted for three quarters of the world’s biotechnology revenues and 82% of world R&D 
spending in biotechnology 30,31. However funding forecast by Batelle/R&D Magazine showed that 
US R&D 32 will have a very slow growth with its high unemployment rate, weak consumer and 
industrial confidence and major concerns over federal spending and deficits.   
 
Pressure of today’s global economy on drug companies to deliver high-quality products within a 
time frame while maintaining profitability could not be bigger in this recession. Drug discovery 
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involves many steps, each of which requires time and money. Ultimately, the success of a 
commercialized drug will depend on Research and Development costs, cycle time associated with 
producing new drugs and cost of launching a new drug to the market while keeping at bay patents 
and competition 23. Typically, an approximate estimate of developing up to the commercialization 
of a new drug may be above 800 million U.S. dollars 33 and typically the drug appears some 10 to 
15 years after discovery 34.  Additionally out of 5000 compounds that enter preclinical testing, 
only five lead compounds make it to human testing while only one breaks through to final clinical 
use 35. In recent years, patents on numerous blockbusters have been expiring so that drug 
revenues worth 70-80 billion U.S. dollars will be lost by 2011 as various drugs go off-patent 23. 
 
Theoretically, nanotechnology should enhance the drug discovery process through 
miniaturization and reliability of assays 23. Not only would research go faster but it is will more 
cost-effective.  For these funding and economic reasons, the need for cheap materials is of the 
utmost importance with as much concern at choosing the most biodegradable, biocompatible and 
non-toxic material as well as commercially feasible method of production.   
 
 
4.2. Drug carrier systems 
 
 
Depending on the size and type of drug carrier system, it is possible to control the release, 
targeting and amount of drugs. The types of nanoparticles for drug delivery (Fig. 3) can be: 
Metal-based nanoparticles (e.g. iron oxide and gold nanoparticles), Lipid-based nanoparticles 
(e.g. phospholipids, liposomes), Polymer-based nanoparticles (e.g synthetic polymers such as 
poly-lactic acids (PLA), poly-lactic-coglycolic acids (PLGA), poly-ε-caprolactone (PCL), poly-
methyl methacrylates, and poly-alkyl cyanoacrylates, or natural polymers such as albumin, 
gelatin, alginate, collagen or chitosan) and finally Biological-based nanoparticles (e.g. Protein-
DNA complexes, protein conjugates, erythrocytes, virosomes).  
24 
 
 
 
Figure 3. Carriers for drug delivery and diagnostics: a) scanning electron microscopy (SEM) image of polymer 
microspheres; b) block copolymers used for synthesis of micelles; c) liposomes; d) solid lipid nanoparticles; e) 
abraxane (albumin bound paclitaxel)-protein-based nanoparticles; f) polyelectrolyte-based layer-by-layer capsules; 
g) dendrimers; h) microbubbles; i) carbon nanotubes and fullerenes; j) PEG-coated polymeric particle; k) quantum 
dots; l) iron oxide nanoparticles encapsulated within polymeric carriers coated with targeting moiety-composite 
nanoparticles. Previously published figures are reproduced with permission. Copyright 2006 Elsevier (f), 2005 Nature 
Publishing Group (g,k), 2005 Elsevier (i). 
 
 
All four categories of nanoparticle carrier systems mentioned above have their benefits and their 
drawbacks and given as a summary in Table 2. For example, one of the drawbacks of lipid-based 
nanocarriers are that they are quickly recognized and removed from the blood circulation thus 
nullifying any possible chance of tumor localization. By modifying the nanocarriers (Fig. 4), it is 
possible to have multifunctional nanocarriers for triggered delivery of cancer therapeutics. This 
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nano-assembly includes imaging molecules, a payload of drugs, ligands for site-specific targeting, 
and a destabilizing lipid that allows for on-demand drug release at the desired site, as well as 
sensors that probe the efficacy of the drug in real time. The use of lipid-based nanocarriers also 
provides a suitable way for the nasal delivery of antigenic molecules 36. Besides improved 
protection and facilitated transport of the antigen, nanoparticulate delivery systems could also 
provide more effective antigen recognition by immune cells. In this sense, the design of 
optimized vaccine nanocarriers offers a promising way for nasal mucosal vaccination 37.  
 
 
Table 2. Summary of the benefits and drawbacks of four types of nanoparticles. 
Type of 
nano-
particle 
Benefit Drawback 
Metal-
based 
Metal-based nanoparticles have strong 
magnetic properties and can be used for 
imaging 
May be ideal for diagnosis and imaging but less 
so for treatment and drug delivery owing to their 
high toxicity 38 
Lipid-
based 
- Improve stability of 
pharmaceuticals. 
- High and enhanced drug content 
(compared to other carriers) 
- Feasibilities of carrying both 
lipophilic and hydrophilic drugs 
- Most lipids being biodegradable, 
Solid Lipid Nanoparticles have 
excellent biocompatibility 
- Water based technology (avoid 
organic solvents) 
- Easy to scale‐up and sterilize. 
- Easier to validate and gain 
regulatory approval 36 
- Tends to produce an interferon-mediated 
immune response 23 
- Liposomes-based drug carriers alone are 
quickly recognized and removed from the 
blood circulation thus nullifying any possible 
chance of tumor localization 39 
- Pay‐load for a number of drugs is too low 
- Drug expulsion during storage occurring 
Polymer
-based 
- Prolonged drug action by 
entrapping the drug within matrices 
40 
- Reduction of side effects 
- Reduced toxicity due to lowered 
dose requirement 23 
- Not the most efficient in targeting and has its 
limitations as to not being able to recognize a 
specific target (ligand or other active site for 
reaction) 
- They are either denatured by the stomach 
environment or eliminated via liver 
metabolism 23 
Biologic
al-based 
Capable of specific target recognition 
i.e ability to deliver drug molecules 
directly into cells 41 and the capacity to 
target tumors within healthy tissue 42 
High risk of transformation or transfection of 
DNA 
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Figure 4. Design principle of an ideal multifunctional lipid-based nanoparticle for targeted and triggered drug 
delivery. Liposomes consist of a matrix phospholipid (cyan), a destabilizing (pore forming) phospholipid (yellow), 
conjugation lipid (green), ligand attached via the conjugation lipid (brown), and a cell death marker such as an 
apoptotic detector (pink). The nanoparticle is loaded with a chemotherapeutic agent (red) and an imaging agent 
(blue) in the aqueous milieu 43. 
 
 
As far as the size of the drug carrier system goes, Table 4 gives an indication of three generations 
of drug carriers. This project will deal mainly with second generation drug carriers that give a 
general route of transportation to the target site. The first generation drug carriers are limited in 
their type of administration and are less efficient via oral administration while the third generation 
drug carrier requires too complex a fabrication process for basic laboratory equipment. 
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Table 3. Generations and examples of nanocarrier systems 44 
 
 
 
For the type of drug administration, oral drug delivery is the most common and convenient form 
of non-invasive treatment despite the fact that peptides and proteins remain poorly available upon 
oral administration. Oral intake also provides the advantage of avoiding pain, discomfort and 
contaminations associated with injections 12. However, compared to injections, oral intake gives 
slower and less effective treatment results, excluding higher chances of allergies, irritations or 
side-effect reactions to the drug. In an effort to target specific parts of the body and deliver the 
right amount of drug, oral drug delivery has to pass through the obstacles that are the gastric acids 
and the gastrointestinal tracts which require proper protective encapsulation substances, easy drug 
loading into the capsules and controlled drug release once the capsules have reached their target.  
Vaccines are so far the most promising applications for orally delivered nanoparticles 12. 
Therefore depending on the type of disease to target, the best type and size of carrier vehicle can 
be chosen. For gastrointestinal targeting, polymer-based nanocarriers especially natural polymer-
based ones, are preferred owing to their physiochemical properties as discussed in the section 
below. 
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4.3. Natural polymers  in drug delivery 
 
It was established in the previous sections that the most convenient and economical form of 
treatment for consumers was orally-administered drugs like tablets and pills. For this form of 
drug delivery, drug encapsulated drug carriers such as polymer-based or lipid-based nanoparticles 
are the prevalent choices. Owing to safety issues and ease of fabrication, metal-based and 
biological-based nanocarriers were ruled out in addition to the fact that for the purpose of this 
project, targeting parts of the human body such as the gastrointestinal tract or the colon requires 
drug delivery systems that can withstand gastric acids of the stomach.  
 
Out of the polymer-based nanoparticles as potential drug carriers to the lower parts of the body 
that remain, natural polymers are preferred for their desirable properties such as biocompatibility, 
biodegradability and functionalization capability. They also exhibit response to stimuli properties 
by reacting to a defined change in temperature or pH 40.Encapsulation of drugs within a 
polymeric scaffold, greater control of the pharmacokinetic behavior of the drug molecule, 
constant flow and slow release of the drug are their most valued abilities 45. Research by Landgraf 
et al 46 showed that conventional oral drug delivery typically follows a first-order kinetics of drug 
release whereby the drug release rate was proportional to the amount of drug remaining in the 
drug carrier. This implied that conventional oral drug delivery occurred with a burst and the rate 
decreased as the amount of drug in the drug carrier decreased as compared to the steady release of 
the nano drug carriers. Steady flow ensures prolonged drug action and reduction in drug dosage 
which minimizes side effects 40. Polymers are also capable of restricting diffusion of low-
molecular-weight compounds in matrix arrangements. Not to mention that natural polymers have 
always been easily obtainable at low cost. 
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The most commonly used natural polymers in the medical arena are Chitosan, alginates, pectin, 
collagen, Gum Damar, Gum copal, hydrogels, Zein, etc. , many of which are used for transdermal 
drug delivery 47 (drug delivery through the skin). Of these only chitosan 48, alginates 49 and 
pectin50 are being studied for orally-administered encapsulated drug delivery targeting the colon. 
 
4.2.1 Biodegradability and Biocompatibility  
It is of utmost importance for health safety and ecological concerns for biological 
mutation that the materials for drug carriers be biodegradable and biocompatible. 
Biodegradation or biotic degradation/decomposition is the chemical dissolution of 
materials by bacteria or other biological means, that is, substances that can be broken 
down or decomposed by naturally occurring microorganisms in the environment. 
Biocompatibility of a material, in the context of drug delivery, is minimal or no immune 
response from the surrounding biological system or the ability of the material to integrate 
with a particular cell type or tissue. Being natural polymers, chitosan, alginates and pectin 
are biodegradable and biocompatible. Both chitosan and Alginates are biodegradable and 
biocompatible but the toxicity of chitosan is still debatable 14. Pectin is also a 
biodegradable and biocompatible material but one problem with pectin formulations is 
that they can swell under physiological conditions which may result in premature drug 
release 51 . With low methoxy-pectin systems issues such as optimal molecular weight 
and degree of esterification, drug diffusivity, interactions with mucosal tissues and 
stability (molecular weight/viscosity/gelation) are still to be addressed 52. 
 
4.2.2 Other Properties 
For its permeability abilities and possible preparation of organic solvent free of 
mucoadhesive particles, chitosan remains the most valued polymeric material used. 
Recent studies by Van der Lubben et al. have demonstrated that large amounts of bovine 
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serum albumin (BSA) or vaccine tetanus toxoid (TT) were easily encapsulated in 
chitosan nanoparticles 53. Other chitosan nanoparticles studies by Alonso’s group as 
carrier systems for transmucosal delivery have shown the potential of chitosan 
nanoparticles in enhancing mucosal absorption on rats and rabbits 54, 55. 
 
However, studies showed that chitosan granules released the drug rapidly at acidic 
medium and slowly at neutral or alkaline medium 48 which is not desirable to target parts 
of the body like gastrointestinal tracts and the colon. Alginates on the other hand are 
known to be resistant to low pH which will make them more resistant to gastric acids. 
Nevertheless, one of the drawbacks of alginates is that it is porous and drug leakage 
occurs by more than 50% which is why alginates are often used in combination with 
CNTs 11 and chitosan 10 to retain the drug. Despite their promising attributes, 
amphiphillic chitosan on the other hand proved to be toxic and the fact that, as chitosan is 
highly swollen and/or dissolved in the acidic conditions of the stomach, the utilization of 
chitosan as a drug carrier is hardly satisfactory for specific targets, for example, the colon 
and large intestine 14.  
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5. ALGINATES 
 
 
5.1 Overview 
 
 
As mentioned in the Introduction, alginate is a polyanionic naturally occurring polymer derived 
from marine kelp mainly brown sea algae. Alginates play an important role in the food and 
beverage industry as stabilizers and thickeners in common products such as jelly, chocolate milk 
drink, ice creams and other desserts. Alginates are used in other industries but pertaining to this 
project, the relevance of alginates in vast food products points out as to the non-toxicity of this 
substance. Table 4 illustrates some of the uses of alginates in the food industry and some other 
industries 56. 
 
Table 4. Functional role of alginates in some common applications 56. 
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Besides the indispensable function alginates play in the food industry, the use of alginates in the 
Pharmaceutical industry has been growing at a very fast pace in the last two decades. Alginates 
are now used extensively as wound dressing, cell culture and transplantation 57 and other research 
on alginates which have been patented 56 have been summarized in Table 5. 
  
Table 5. Some alginate formulation patents for cell transplant 56 
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5.2 Physiochemical Properties of Alginates 
 
 
5.2.1. Viscosity 
The viscosity of an alginate solution is proportional to the concentration of alginates and 
the length or number of monomer units in the alginate segment as measured by its 
molecular weight 58. This means that at the same concentration, alginates with longer 
segments or higher molecular weights were found to be more viscous so that viscosity of 
alginate solution can be affected by both the concentration and the molecular weight of 
the constituent polymeric segments. 
 
5.2.2. Sol-gel transformation 
In the presence of a divalent cation, aqueous sodium alginate solution can undergo a sol-
gel transformation by three mechanisms: external gelation, internal gelation and gelation 
by cooling. For the external gelation, gel formation occurs instantly as crosslinking 
cations diffuse into the alginate solution at room temperature. In the internal gelation 
method, an insoluble calcium salt is first added to the alginate-drug solution and free 
calcium ions are subsequently liberated by pH adjustment with glacial acetic acid 59. 
Sequestrant such as trisodium citrate can also be employed to further control the reaction 
rate by competing with the alginates for the free calcium ion. The pH condition, amount 
and particle size of the insoluble calcium salt have been reported to affect the releasing 
rate of cations 59. 
 
For alginate gel formed by cooling, sodium alginate, calcium salt, and calcium 
sequestrant are dissolved in a hot medium of 90 °C and then allowed to set through 
cooling 60. At high temperature, the high thermal energy of the alginate chains prevented 
polymeric alignment and irreversibly destabilized any non-covalent intra-molecular 
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bonding between neighboring chains 60. Eventually, upon cooling at a lower temperature, 
the reestablishment of the inter-molecular bonds between the polymer chains facilitated 
the formation of an ordered tertiary structure and resultant homogeneous matrix 61. 
 
The extent of cross-linking largely affected the quality of the matrices formed. In 
particular, the gel strength, which measures the mechanical stability of cross-linked 
matrices, has been studied by compression testing of alginate pellets by Martinsen et al 62. 
It was found that alginate matrices made from a high content of guluronic acid tended to 
be rigid and brittle, while more elastic gels were produced from alginates of low α-L-
guluronic acid content 63. Alginates with a guluronic acid content greater than 70% and 
an average length of guluronic blocks higher than 15 were reported to exhibit less 
shrinkage, good mechanical strength and better stability but greater porosity 62. These 
factors are also discussed in relation to drug release from alginate matrices in the next 
section 
 
It is good to note that an increase in buffer concentration (citrate or phosphate buffer at 
pH 7) causes increased swelling and rapid disintegration of the alginate pellets, with dire 
consequences to the possible encapsulated materials, enhanced bioactivity and 
mechanical stability were reported for alginate-encapsulated cells surface modified with 
polyacrylamide though the cell performance was affected by the type of cross-linking 
cations 64.  
 
5.2.3. Drug release from alginate matrices 
Alginates offer an inert environment ideal for encapsulation of bioactive compounds in 
addition to the ability of the alginate matrix to control drug release at a desirable rate 56. 
The main release mechanism in encapsulated drugs from alginate pellets is by diffusional 
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processes through pores and the release is facilitated by the degradation of the polymeric 
network 56. Alginate composition plays an important role in the porosity of gel matrices. 
It was found that an increase in alginate content increased porosity, enhancing water 
uptake ability and drug release 65. The effect of divalent cations on the gel porosity was 
also investigated using various concentrations of CaCl2 66. The results showed higher 
drug release rates with increased sodium or calcium contents and high matrix porosities. 
However, drug release was limited by ionic strength effect at very high concentrations of 
calcium while high sodium contents (molar ratio of Na+/Ca2+ > 30) may compete with the 
gelating Ca2+ in the alginate carboxyl groups, promoting weak gel formation 62. 
 
5.3 Pharmaceutical applications  
 
Oral controlled-release tablets, prepared by compressing the drug and a dry mixture of sodium 
alginate and calcium, showed gradual dissolution and progressive drug release in the 
gastrointestinal fluid 56. Another alginate formulation for oral administration included sodium 
bicarbonate which released carbon dioxide in an acidic medium. The gas produced increased the 
floatability of the gel network, enabling sustained release of drug 67. The formation of floating 
raft-like alginate structures on the stomach contents could mechanically inhibit gastric reflux 68 
and decrease drug loss through the gastric wash ups. Alginates had also been investigated in the 
formulation of nanoparticles for mucosal vaccination 69. 
 
Concerning research carried out on Bee Venom drug encapsulated micro carriers, studies by Xing 
et al. 49, showed that calcium alginate gel beads could be a potential system for colonic drug 
delivery. The study showed a significant dependence of drug release on the coating membrane 
which in this case was Eudragit S100 (methacrylic acid copolymer B) in an aqueous phase using 
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a fluid-bed spray coater. However, in this study the gel beads were of the order of microns which 
might give different results for nano beads.  
 
The potential issues of using alginates as a drug carrier might be the porosity of the gel matrix. 
Furthermore, despite many years of extensive research, the loading and release mechanism by 
crosslinked alginates gels are still not fully understood. 
 
5.4 Proposed Idea 
 
In Chapter 3, the advent of nanotechnology in areas of medicine especially in drug delivery has 
been presented followed by a review of the different types of drug carrier systems and their 
desired characteristics as drug carriers. It was established on health safety and economical 
grounds that natural polymers were the most reasonable drug carriers for simple drug 
encapsulation to target the parts of the body like the colon or the gastrointestinal tracts. It was 
also established on the grounds of consumer choice and potential commercialization of the drug 
on the market that oral administration of the drug in forms of tablet, capsules or other oral forms 
of drug intake, was the prevalent form of administration. Finally in this section the choice of 
crosslinked alginate gels among all the other natural polymers as the ideal material for a research 
study on their potential use as drug carrier was discussed. 
 
The novel idea for this project will be therefore using the efficacy of nanotechnology, the desired 
characteristics of crosslinked alginates in terms of the sensitive stimuli-response to pH (which 
will be open for future work) and the resistance of crosslinked alginates to gastric acids to 
formulate a nano drug carrier in the shape of a tube for GI or colon targeting.  The next chapter 
will focus on the different ways to produce one-dimensional nanostructures and the most practical 
and cost-effective means of fabrication in a simply equipped laboratory. 
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6. FABRICATION OF ONE-DIMENSIONAL NANOSTRUCTURES 
 
 
One-dimensional nanostructures are structures at the nanoscale level which can be described as 
wires, rods or tubes which have lateral dimensions in the range of 1 to 100 nm. In general, nanorods 
or wires are completely filled long wires while nanotubes are hollow wires. However this 
description of 1-D nanostructure is quite limited since many of the research published had 
nanostructures approaching 300 nm or less.  
 
The choice of nanotube structure as drug carrier instead of choosing nanoparticles which are 
spherical pertains to the fact that elongated shapes have greater surface area (Fig. 5) which would 
aid in the potential mucoadhesiveness of the drug carrier to the inner walls and tissues of the body 
so as to enhance drug intake.  
 
Figure 5. Schematic representation of higher contact surface area presented by elongated particles in comparison 
with spherical particles, thereby having a higher potential of targeted delivery 70. 
 
Nanoscale fabrication can be either “top-down” which entails reducing large pieces of materials all 
the way down to nanoscale or “bottom-up” whereby nanoscale products are created by building them 
up from atomic or molecular scale components. Both bottom-up (Self-assembly and Self-
organization) and top-down (EUV and X-ray lithography, E-beam lithography, Ion-beam lithography, 
Scanning probe lithography and Soft-lithography) fabrication can be costly because of the various 
equipment and processes involved but there is more possibility to reduce the cost of production 
significantly with bottom-up by using ingenuity and with simple laboratory equipment. For the sake 
of this project, emphasis will be placed on the bottom-up approach for potential laboratory 
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fabrication.  The most common modes of fabricating 1-D nanostructures which are Nano-/Mesoscale 
self-assembly (MESA) through growth and Template-assisted self-assembly (TASA) will be 
discussed below as well as some other techniques. 
 
6.1 Overview: Methods of fabrication  
 
Self-assembly methods of fabrication have the attractive features that self-assembly structures 
occur spontaneously, are often at or close to thermodynamic equilibrium, tend to reject defects, 
and also have self-healing capability and are often more ordered than other systems. Self-
assembly method offers a simple, parallel and low-cost processing alternative to the expensive 
top-down processes like nanolithography. 
 
The definition of molecular self-assembly is given as the spontaneous organization of molecules 
into stable, structurally well-defined aggregates. Similarly Nano- or Mesoscale assembly is the 
spontaneous organization of nano-sized or almost micro-sized particles into stable and 
structurally defined aggregates. The forces behind self assembly at the molecular scale involves 
H-bonding, hydrophobic interaction, electrostatic forces, and van der Waals forces while at the 
Nano- and Mesoscale the forces involved in the process are capillary forces, external fields 
(gravitational, centrifugal, magnetic, electric, optical), surface tension, electrostatic forces, shear 
forces, and molecule-based interactions. Most of the self-assembled polymers use the electrostatic 
forces of hydrophilic or hydrophobic branches to assemble (Fig. 6)  
 
 
39 
 
 
Figure 6. Self-Assembled Monolayers (SAMs) 71 
 
 
The process behind 1D nanostructure formation is about crystallization and as concentration of a 
solid reaches a certain saturation point, they start to rearrange or aggregate into small clusters. 
Materials with highly anisotropic crystal structures easily grow from self-assembly. Different 
materials assembly differently for example the Tobacco Mosaic Virus assembles along a spiral 
axis (Fig. 7)  
 
Figure 7. Schematic of a Tobacco Mosaic Virus and the self-assembly mode along the spiral axis 72 
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Nano- and Mesoscale self-assembly can be achieved by chemical vapor deposition method 
(CVD) via solid-solid interface in the vapor state. Chemical Vapor Phase deposition method 
consists of vaporizing the solid to supersaturation at a relatively low level and growth will be 
driven by the axial screw dislocations 73. This method fabricates mostly nanowires or 0D 
nanolayers and hardly any nanotubes which is why this method of fabrication will not be 
discussed further in this project. It also is generally used on most inorganic materials that can be 
vaporized or synthesized under reduced pressure.  
 
Solution-based chemical capping methods for solid-liquid interface and liquid-liquid interface in 
solutions is also possible with the use of a seed initiator or catalyst at the surface. For example 
Song et al. 74 studied Molybdenum Chalcogenide Molecular wires and found that in the presence 
of organic surfactants of opposite charges these self-organize into molecular wires. Further 
studies are in process to fully understand the self-assembly of this material. However, in the case 
of organic nanostructures which mainly involve weak van der Waals or hydrogen bonding forces 
to hold organic molecules together, many attempts to grow 1D nanostructure via vapor deposition 
technique did not yield homogeneous nanowires 16. 
 
Another method of self-assembly is the sonochemical approach. For example, selenium 
nanowires formation can be induced at room temperature by sonication 75. When a short pulse of 
sonication was applied, the selenium colloid underwent disruption and aggregation but wire 
growth mainly originates from the surfaces of a-Se phase colloids and occurs in a matter of hours. 
 
Layer by layer (LbL) self-assembly makes use of the electrostatic forces between two substances 
to self-assemble. The mechanism (Fig. 8) involves a charged substrate being immersed in a 
solution of the oppositely charged colloid to absorb the first monolayer. The modified substrate is 
washed to remove any unbound material and prevent contamination of the subsequent oppositely 
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charged colloid. The process is carried out between the two oppositely charged substances 
depending on the intended number of layers. Concerning a self-assembly method for sodium 
alginate which has more van der Waals forces than ionic forces, the substrate surface needs to be 
charged with PEI 10 which is positively charged that will attract the negatively charged aqueous 
alginate. LbL self-assembly offer the possibility to control wall thickness, have several types of 
synthetic/natural colloids available for LbL 76 and require much fewer amounts of colloids (~1%) 
compared with a minimum of about 10% with conventional techniques 77. 
 
 
 
 
Figure 8. A schematic illustration of the alternate adsorption of the polyelectrolyte species to produce a multilayered 
structure. (A) Dipping in a polycation (example) followed by (B) rinsing in a solvent for the polycation with (C) 
dipping in a polyanion and (D) rinsing in a solvent for the polyanion. The process is repeated n times to produce (E) 
the multilayered construct 76 
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6.2 Template-assisted method  
 
 
Template-assisted method entails using a template or mold as scaffold with which materials can 
be shaped depending on the morphology of the template. A number of templates have 
successfully been used to shape materials, for example by using the step edges present on the 
surfaces of a solid substrate, channels within a porous material, or biological macromolecules 
such as DNA strains or rod-shaped viruses 73. 
 
Template-assisted methods are generally direct route to synthesizing the nanostructures and may 
provide a simpler and cost-effective procedure allows duplication of complex topology present on 
the surface of a template in a single step 73.   The different types of template-assisted methods fall 
into roughly four categories: Template-assisted method against features on solid substrate (Fig. 
9), channels in porous materials (Fig. 10), Template-assisted method against self-assembled 
molecular structures (Fig. 11) and Template-assisted method against existing nanostructures (Fig. 
12). Table 6 gives a brief summary of the advantages, disadvantages and uses of the different 
template-assisted methods.  
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Figure 9. Schematic illustrations of procedures that generate 1D nanostructures by A) shadow evaporation; B) 
reconstruction at the bottom of V-grooves; C) cleaved edge overgrowth on the cross-section of a multilayer film; 
and D) templating against step edges on the surface of a solid substrate 73. 
 
 
 
 
 
 
 
 
Figure 10. Schematic of drawings illustrating the formation of nanowires and nanotubes by filling and partial filling 
the pores within a porous membrane with the desired material or a precursor to this material 73. 
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Figure 11. Schematic illustrations showing the formation of nanowires by templating against mesostructures self-
assembled from surfactant molecules: A) formation of a cylindrical micelle; B) formation of the desired material in 
the aqueous phase encapsulated by the cylindrical micelle; C) removal of the surfactant molecules with an 
appropriate solvent (or by calcinatins) to obtain an individual nanowire. D-F) similar to the processes illustrated in 
(A-C), except that the exterior surface of an inverted micelle serves as the physical template 73. 
 
 
 
Figure 12. A) TEM images of Ag/SiO2 coaxial nanocables that were prepared by directly coating silver nanowires 
with an amorphous silica sheath using the sol-gel method. B) A TEM image of silica nanotubes prepared by 
selectively dissolving the silver cores of Ag/SiO2 nanoscales in an ammonia solution with approximate pH 11 
[103]73. 
 
 
45 
 
Table 6. Summary of the advantages, disadvantages and examples of different types of template-assisted method 
Type Advantages Disadvantages  Some examples 
1. Template-
assisted 
method 
against 
features on 
solid 
substrate 
- fabricates large parallel arrays 
on surfaces of solid supports 
- Releases the nanowires into 
free-standing form or 
transferred onto surfaces of 
other substrates 
- Cleaved-edge overgrowth 
provides quantum surfaces 
with more uniform 
morphologies than e-beam or 
optical lithography 
- Limited to those structures 
that can be fabricated along 
the natural cleavage 
directions of a substrate and 
along lattice planes 
- Limited to metal and 
nonmetal elements or 
compounds. 
- Produces only nanowires 
and no nanotubes 
Ge nanowires on 
Si(100) 
substrates 78 
 
Fe nanowires on 
NaCl(110) 
crystals 79 
 
2. Template-
assisted 
method 
via 
Channels 
in porous 
materials 
- Dimension and composition of 
nanostructure can be easily 
controlled by varying 
experimental conditions 
- Cost-effective but might 
require some ingenuous idea to 
introduce the substance into 
the pores. 
- Requires a way either by 
vapor-phase sputtering, 
liquid-phase injection or 
solution-phase chemical or 
electrochemical deposition 
to get the substance inside 
the pores 
- Low yield of filling as 
reported by Green et al. to be 
about 2% with Ru wetting of 
CNT’s 80 
Polystyrene 
nanorods/nanotu
bes 
 
Ag nanowires81 
 
Titania 
nanowires 
(electrophoresis)
82 
3. Template-
assisted 
method 
against 
self-
assembled 
molecular 
structures 
- Metal nanowires could be 
synthesized as regular arrays 
rather than randomly oriented 
samples 
- Though yield of production 
can be large, preparation and 
removal of the micellar 
phase is often difficult and 
tedious. 
Synthesis of 
BaCrO4, BaSO4 
and BaWO4 
nanorods with 
monodispersed 
dimensions 83 
 
Gold nanorods84 
4. Template-
assisted 
method 
against 
existing 
nanostruct
ures 
- Facilitates multiple processes 
from direct coating to LbL 
processes depending on the 
surface interaction with the 
existing nanostructure. 
- Allows incorporation of many 
functions (e.g. luminescent, 
ferromagnetic, ferroelectric, 
piezoelectric and 
superconducting) into an 
individual nanowire 73 
- Generates complex patterns 
with arbitrary designs using 
many tools that have been 
developed in biochemistry 
- Requires thin deposition of 
Ti on the walls for Au, Pd, 
Fe, Al and Pb nanostructures 
or else only discrete particles 
are obtained implying some 
wetting issues 
- Involves complex and long 
process involved 
- Difficult to achieve tight 
control over the composition 
and crystallinity of the final 
product and final products 
are often structurally 
polycrystalline 73 
Ag and Pt 
nanowires 
against DNA 
strands 85 
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Template-assisted method using porous membranes has the advantages of offering the easiest and 
cost-effective production of polymer nanostructures as compared to other template-assisted 
methods mentioned above. In this project, the most basic template-assisted method using the 
concept of wetting is used since it relies only on the capillary action of the solution.  
 
Having established the type of template-assisted method to use the choice of the template itself is 
still to be decided. Two types of porous membranes commonly used in syntheses are polymer-
films containing track-etched channels and alumina films containing anodically etched pores or 
also known as Anodic Aluminum Oxide (AAO). Unlike the polymer membranes fabricated by 
track etching, the pores in AAO membranes have a higher pore density 73. 
 
A special note for additional enquiry is that among the template-assisted methods that was not 
discussed above but which gave successful results is electropolymerization. 
Electropolymerization uses polymerized chains that respond to an applied electric field to migrate 
towards one of the electrodes. This however is limited to certain electron rich aromatic monomers 
or monomers that have to be electropolymerized which in our case presents too complex a 
process for simple laboratory experiment.  
 
 
6.3 Anodic Aluminum Oxide Templates 
 
 
Anodic aluminum oxide membranes (Fig. 13) are produced by a two-step anodization of pure 
aluminum (99.99%) in an acidic solution 86-88. Factors such as time of anodization, voltage and 
type of electrolyte used will determine the pore size, separation and length of the templates. 
Commercial AAO having pores which are not as perfect as homemade AAO 16, is a good enough 
starting template to use for simple and rough production of crosslinked Sodium alginate 
nanotubes. Since AAO is used as a physical mold, it needs to be disintegrated chemically to 
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liberate the nanostructures and using the fact that aluminum oxide is amphoteric, it can easily be 
dissolved in aqueous NaOH, KOH or an acid such as H3PO4 16. The reagent used to dissolve the 
template should not affect the nanostructure material or else it will compromise the whole 
fabrication process. 
 
 
Figure 13. (a) Scanning electron microscope (SEM) image of a cross-section of an AAO template with 200nm pore 
diameter. (b) SEM of a 200nm AAO template surface collected using a Philip XL30 FEG16. 
 
Wetting template-assisted method therefore offers the most convenient, most economical and 
general method of synthesizing 1D nanostructures. Theoretically, capillary action should be 
enough to force the polymer solution to spread evenly inside the pores of the AAO template and 
as the polymer is evaporated, a thin layer of the polymer will coat the inside of the pores. The 
limitations in this method are that the polymer used should be water soluble which in our case is 
appropriate since alginates can be dissolved at high temperature in water and the polymer should 
have a low viscosity which will require proper adjustment of the concentration of the sodium 
alginate solution. Attempts at using the wetting template-assisted method at producing nanotubes 
have been successful with polystyrene 89-91. Strong capillary action will likely produce perfectly 
shaped nanotubes with lengths almost equal to the length of the template.  
48 
 
One foreseeable problem that might arise with the production of the crosslinked sodium alginate 
is that the crosslinking will need to take place inside the template pores which implies that 
infiltration of both crosslinking reagents inside the template should be possible. The following 
chapter will detail the methodology used to produce crosslinked Sodium alginate and Calcium 
chloride nanostructure while Chapter 8 will give an analysis of the results from the methodology 
used. 
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7. METHODOLOGY: TEMPLATE-ASSISTED 
 
 
Various sources for typical commercial materials used in the nanotechnology domain were 
examined. In the present study, emphasis will be made more on treatment rather than on 
diagnosis by designing drug carrier systems that can be orally-administered which will target 
the lower part of the human body like the gastrointestinal tract or the colon. A simple survey 
of materials mostly polymers carried out among the most commonly used as drug 
carrier/drug delivery systems included chitosan, chitosan/alginate 10, alginate/CNT 11 (carbon 
nanotubes) and poly(D,L-lactic-co-glycolic acid) (PLGA) 92. However, the natural polymer 
alginate was chosen as the best candidate for drug carrier owing to its biocompatibility, 
biodegradability, easily obtained at a low cost and non-toxic. 
 
It was established in Chapter 6 that template-assisted method using wetting of AAO 
membranes was the most economical and simplest fabrication technique to be performed in a 
basic laboratory. Some works have been discussed which indicated successful fabrication of 
crosslinked SA-CaCl2 nanostructures. The methodology presented below will give an outline 
of the technique used and ways to overcome some of the difficulties encountered in the 
production of the nanotubes such as deposition of the Calcium on the top surface of the 
membranes preventing further infiltration or the correct concentration of SA for infiltration 
by capillary action. 
 
7.1 Materials 
 
Sodium alginate powder (white at Mw=12 000-600 000g/mol)and anhydrous NaOH pellets were 
purchased from Sigma Aldrich, 0.1M CaCl2 purchased from Fischer Scientific and Anodisc 
commercial AAO templates purchased from Whatman Inc (with an average pore diameter of 
200nm, a 60µm thick membrane and a pore density close to 1011 pores/cm2).Sodium alginate 
powder (brown at Mw=60-40 000g/mol) was purchased from Sigma Aldrich and transparent 
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drinking straw of approximate diameter 0.6cm was used as simulated nanopores for the template in 
the pre-experimental section.  
 
7.2 Pre-Experimental  
 
This part consisted of preliminary experiments to observe the characteristics and behavior of the gel 
at the macro level before the nano-level experiments are carried out. This was done to limit the 
number of variables for the design of the experimental method and to prevent unnecessary 
experiments which were carried out at the macro level instead to observe the effect of the molecular 
weight on the morphology. Based on these observations, the nano-level methodology was fine-
tuned and provided some explanations for the results obtained in the Experimental section below. 
 
7.2.1 Molecular weight effect on gel morphology 
Brown SA (Mw=60-40 000g/mol) and white SA (Mw=12 000-600 000g/mol) were each 
poured on a surface and made to dry at room temperature. After drying, the dried up SA 
were immersed in 0.1M CaCl2 and the morphology of the gel formed were observed. 
 
7.2.2 Length of CaCl2 infiltration during crosslinking 
Brown SA (Mw=60-40 000g/mol) and white SA (Mw=12 000-600 000g/mol) were  
each poured into the straw and dipped into CaCl2 (0.1M). The SA filled straws were 
dipped for two weeks to allow ample time for CaCl2 infiltration. Morphology of the gels 
formed and the length of infiltration of the CaCl2 through the bottom end of the straw 
were observed.  
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7.3 Experimental 
 
The four variables to be analyzed were dipping time period of the template into the first reagent, 
number of times of dipping, concentration of sodium Alginate and the concentration of calcium 
chloride. The basic procedure was outlined below and consists of varying one of the four variables 
while keeping the other three variables constant as given in Table 7. 
 
7.3.1 Preparation of templates 
The templates were dipped into Calcium chloride on one side facing down for some time 
td and dried for at least 2-3h at room temperature in an upright vertical position. The 
dipping procedure was repeated such that N=2, with the same side facing down as the 
previous dipping step followed by drying in the upright position. The concentration of 
calcium chloride was 0.1M. 
 
7.3.2 Crosslinking of  SA and CaCl2 to form gels 
After the templates have been dried for the Nth time, they were dipped into Sodium 
Alginate of concentration [SA] with the same side facing down during dipping into 
calcium chloride for about 24h. Aqueous SA was prepared in de-ionized water, heated to 
about 50°C under continuous magnetic stirring. Concentration of SA was varied as 
0.5%wt, 0.75%wt, 1%wt and 2%wt with trial A, time of dipping of template in CaCl2 
was varied from 10 minutes, 1h and 4h with trial B, number of times of dipping is varied 
from 1 and 3 with trial C and concentration of CaCl2 varied from 0.5M to 1M in trial D. 
 
 
 
 
 
52 
 
Table 7. Experimental trials for the variables identified as concentration of SA, dipping time, number of dipping and 
concentration of CaCl2. 
Trials [SA]/%wt td N [CaCl2] 
A1 
A2 
A3 
A4 
0.5 
0.75 
1 
2 
24h 2 0.1M 
B1 
B2 
B3 
1 10 min 
1h 
4h 
2 0.1M 
C1 
C2 
1 24h 1 
3 
0.1M 
D1 
D2 
1 1h 2 0.5M 
1M 
 
 
7.3.3 Post-preparation of templates with gel 
The gel-filled templates were removed from the SA solution and the excess gel was 
scraped gently off the surface.  The crosslinked SA-CaCl2 templates was then left to dry 
in the refrigerator in an upright position for at least 24h. Low temperature prevented the 
gel from losing its structural strength too quickly thus altering their shapes while drying. 
 
7.3.4 Dissolving of  the template 
The crosslinked SA-CaCl2 templates were dissolved into 0.5M of NaOH and sonicated 
for at least 10h. The mixture may be centrifuged and have the NaOH solution replaced 
and sonicated again if templates are still visible to the naked eye. 
 
7.3.5 Preparation of SEM samples 
The sonicated mixture was centrifuged before it was washed with de-ionized (DI) water. 
The mixture was centrifuged again before the deposited colloid at the bottom of the vial 
was sucked and left to dry on carbon tape at room temperature in a fume cupboard. 
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7.3.6 Characterization  
The polymer-filled undissolved templates and morphology of the crosslinked SA-CaCl2 
nanotubes were gold/vanadium coated under vacuum and examined under JSM7000 
scanning electron microscope (SEM, 4 kV).  
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8. RESULTS 
 
The nanostructures typically consisted of nanotubes of 150-300nm wide, 1-15µm long and 60-75nm 
thick (Fig.14). Optimum conditions for obtaining complete nanotubes with no agglomeration were 
1wt% SA, 0.1M CaCl2, dipping time in the range of 1h<td<4h and number of times of dipping at two. 
Manipulation of the concentration of SA, dipping time, number of dipping and concentration of CaCl2 
all contributed to control the nanotubes thickness as well as their mechanical integrity and strength 
after evaporation of water.  
 
 
   
Figure 14. SEM images of crosslinked SA-CaCl2 gel formed under the optimum conditions of 1wt% SA, 0.1M 
CaCl2, 1h<td<4h and N=2. Results show that the nanostructures formed were nanotubes of 150-300nm wide (left), 
1-15µm long (right) and 60-75nm thick (left) approximately. 
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8.1 Order importance 
 
The infiltration method used was founded solely on the capillary action of the solution as the 
template was immersed completely into CaCl2 and SA solutions, noting the side facing down. As 
the layer of solvent evaporated, a layer of the substance was deposited on the inside of the walls 
of the AAO pores and the thickness depended on the concentration of CaCl2, dipping time and 
number of times of dipping. It is to be noted that the order of sequential dipping was significant. 
Immersion of the template first into SA followed by CaCl2 yielded no visible nanostructures 
while the reverse gave satisfying results. The SA upon evaporation did not stick uniformly to the 
walls so that the nanostructures formed had no intelligible shape whereas the CaCl2 was deposited 
more uniformly on the walls without collecting at some specific places.  
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8.2 Commercial AAO v/s homemade AAO 
 
A problem that arose from the commercial AAO templates as reported by Rabih et al. 16 was that 
they were cone shaped. The diminished diameter at the ends which was about half the diameter at 
mid-distance (Fig. 15), hindered the infiltration of the viscous SA into the cavities which might 
explain the low yield of the nanostructures. As a result, most of the gelling part also occurred at 
the surface of the template (Fig. 15) which blocked the infiltration into the templates and formed 
a film. 
 
 
Figure 15. SEM image of AAO template with cone shaped ends with diameter about half that of inner diameter. 
 
 
The non-uniformity of the template pores resulted in uneven nanostructures which had different 
lengths and shapes. Some template pores were only 0.5µm to 2µm in length from the opening. 
Studies carried out on template infiltrated polystyrene nanowires 12 with home-made AAO 
templates produced perfectly formed nanorods. 
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8.3 Effect of infiltration for varying concentration of CaCl2 on morphology of nanostructures 
 
In the case of CaCl2 infiltration, at high concentration of 1M a film of crystallized CaCl2 tended 
to get deposited on the top surface thus blocking the passage of the SA as a thick layer of 
crystallized CaCl2 formed at the surface (Fig. 16). The compromise was between the length and 
mechanical strength of the nanostructures formed. Low concentration of CaCl2 at 0.1M filled the 
templates almost completely but resulted in nanostructures with relatively low mechanical 
strength whereas the high concentration CaCl2 at 0.5M filled the templates up to only one fifth 
and resulted in short fully-formed nanotubes (less than 3µm) that did not collapse upon 
evaporation of water (Fig. 17). At 1M CaCl2 there was no observable nanostructures in the SEM 
which was explained by the thick deposited layer of CaCl2 (Fig.16). 
 
 
Figure 16. SEM image of template filled with 1M CaCl2 at N=2 and td=1h shows template pores almost 
completely filled at the ends and thick film formed at the surface preventing further potential infiltration of the 
SA. 
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Figure 17. SEM image of 1wt% SA crosslinked with 0.5M CaCl2 at td=1h and N=2. Results show that 
dispersed perfectly shaped nanotubes were formed at 2-3µm in length, 250-300nm in width and 50nm in 
thickness approximately. 
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8.4 Effect of removing excess CaCl2 from  surface 
 
When templates were removed from CaCl2 for N=2, the excess CaCl2 had to be removed to 
prevent thick crystallized CaCl2 depositing on the surface. SEM image (Fig. 18a) depicted a thick 
crust on the surface when the templates were left to dry with the excess CaCl2 and SEM images 
(Fig. 18b) depicted SEM image of template surface dabbed gently with absorbing paper to 
remove some of the excess CaCl2. Another method to remove the excess CaCl2 was washing the 
template with acetone after dipping. Results confirmed thicker film deposited on surface when 
CaCl2 was not removed compared to that when template was dabbed gently with absorbing paper. 
In the case of excess CaCl2 on surface, the pores were filled with thick layer of CaCl2 (Fig. 19a) 
which filled the pores almost completely up to about 6-10µm from opening. In the case of using 
absorbing paper, there were some occasional agglomerated crystallized CaCl2 on the surface and 
the CaCl2 were deposited non-uniformly on the inner walls of the template (Fig. 19b). Finally 
when rinsed with acetone, there were almost no to few deposition of CaCl2 on the surface of the 
template while the CaCl2 was deposited uniformly on the inner walls of the template to about 
100nm in thickness (Fig. 19c).  
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Figure 18. SEM images of templates with surfaces (a) left to dry with excess CaCl2 at room temperature, (b) 
dabbed with absorbing water, (c) rinsed with acetone and (d) clean without any dipping. Results show that with 
excess CaCl2 left to dry a thick layer of CaCl2 is deposited on the surface and infiltration occurs only up to 6-
10µm from opening. Gentle dabbing with absorbing paper still leaves some places with thick layers of 
deposited CaCl2. When rinsed with acetone the surfaces are void of deposited layer and are almost comparable 
to a clean pristine template. 
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Figure 19. SEM images of template immersed once in 0.1M CaCl2 for 1h at N=2 and (a) left to dry with excess 
of CaCl2 forming thick film of deposited CaCl2 at the surface (b) dabbed gently with absorbing paper with some 
deposited CaCl2 on the surface (c) rinsed with acetone with almost no crystallized CaCl2 on surface. Results 
show that when rinsed with acetone, there is uniform deposition of CaCl2 on the inner pore walls. 
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8.5 Concentration of SA and molecular weight on morphology 
 
At higher concentration of SA, the polymer chains were more interlinked with higher number of 
branches. During crosslinking, the branches linked with the CaCl2 in different ways thus 
distorting the solid gel as the gel expanded outside of the straw. Preliminary experiment (Fig. 20) 
carried out on the effect of molecular weight of Brown SA (Mw=60-40 000) and white SA 
(Mw=12 000-600 000) depicted distortion of the gel. Brown SA at concentration of 5wt% 
showed less distortion at the straw end than the SA with the same molecular weight at 
concentration of 10wt%. White SA showed small to almost no distortion when the gel expanded 
out of the straw of diameter 0.6cm (Fig.21). It is noted however that the lower molecular weight 
SA gave a rod-like shape with a diameter matching that of the mold whereas with the higher 
molecular weight SA, syneresis occurred as the gel was formed and the resulting rod-like shape 
had a smaller diameter.  
 
In terms of length, since syneresis occurred with higher molecular weight SA, infiltration of 
CaCl2 through the straw was more feasible thus giving a rod-like structure that was twice as long 
as that with the lower molecular weight SA (Fig. 21). Results (Fig. 22) confirmed the retracted 
shape “higher-Mw gel” took when it was crosslinked as compared to that of “lower-Mw gel” 
which tended to keep its original shape. 
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Figure 20. Image of straw filled with 2 different molecular weights of SA and dipped in 0.1M CaCl2 for 2 weeks. In 
(b) molecular weight of SA was 60-40 000g/molat 5wt% (left), molecular weight of white SA was 12 000-600 
000g/molat 2wt% (middle) and molecular weight of SA was 60-40 000g/molat 10wt% (right) 
 
 
 
64 
 
Figure 21. Image of rod-like shapes obtained from crosslinking of 2wt% SA at Mw=12 000-600 000g/mol of 6.6cm 
long (left), 5wt% SA at Mw=60-40 000g/molof 3.8cm long (middle) and 10wt% SA at Mw=60-40 000g/mol of 
3.6cm long (right) crosslinked with 0.1M CaCl2. Straw of diameter 0.6cm was used. 
 
 
 
 
 
 
Figure 22. Image of 2 droplets of SA (a) left to dry with concentration of 10wt% (left) and 5 wt% (right) at Mw=60-
40 000g/mol and (b) crosslinked with 0.1M CaCl2. Results show that the higher the Mw, the gel formed tends to 
retract on itself compared to that of the lower Mw which keeps the same flat original shape before crosslinking. 
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8.6 Effect of concentration of SA 
 
Low concentration of SA was more uniformly coated on the inner pore walls than high 
concentration of SA which agglomerated in the pores and blocked further infiltration (Fig. 23). 
High concentration SA at 2wt% only filled the templates to about a third or less of the template 
length of 60µm. Low concentration of SA at less than 1wt% filled the templates almost half way 
while at 0.75wt%, the SA filled the template almost completely (Fig. 24). This gave a rough 
indication of how the SA infiltrated a CaCl2-coated-template for crosslinking. SA infiltration will 
be even less than the results obtained with CaCl2when the templates were filled with SA only. 
The length of the nanostructure formed then will be much less than the length of the infiltrated 
SA as observed (Fig. 24). This occurred due to the gel-diffusion boundaries because upon contact 
with the CaCl2, the SA was crosslinked and formed a solid gel. The gel allowed some more SA to 
be crosslinked further through diffusion with CaCl2 found deeper into the template pores. At 
some point, diffusion ceased to occur and crosslinking between SA and CaCl2 was hindered by 
the gel-diffusion boundary. This explained the maximum length of the nanostructures formed of 
about 15µmwith 1wt % SA and 0.1M CaCl2 (Fig. 14)since though with 0.75wt%  SA infiltration 
is greater, the nanostructures are not strong enough and will collapse leaving no evidence.  
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Figure 23. SEM images of top and side views of template infiltrated with only SA(Mw=12 000-600 000g/mol) at 
concentrations of(a) 0.75wt%, (b) 1wt% and (c) 2wt%. Results show that at higher the concentration of SA the pores 
are blocked with agglomerated dried SA while top surfaces have thick layers of SA preventing further potential 
infiltration. 
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Figure 24. SEM images of side view of templates infiltrated SA with concentrations at (a) 0.75wt%, (b) 1wt% (c) 
2wt% and (d) clean template without any dipping. Results show that at 0.75wt% SA, infiltration is almost complete 
with some agglomeration, at 1wt% infiltration is about half the template thickness and at 2wt% the infiltration is 
only about a third of the template thickness. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) (b) 
(c) (d) 
68 
 
8.7 Effect of time of dipping td and number of times of dipping N 
 
Nanotubes of the polymer were successfully obtained at a dipping time period of 1h and at 
number of dipping times at N=2 (Fig. 14). Dipping time td =10 minutes yielded nanostructures 
that were distorted and not completely formed and dipping time of 4h or greater yielded fully 
formed nanorods that were stuck in a bundle (Fig. 25). This was explained by the fact that at 
small values of td, not enough CaCl2 were deposited on the inner walls such that the gel formed 
were weak and collapsed into distorted shapes. At large values of td, the excess of CaCl2 built on 
the template walls did not get completely crosslinked with the SA. As templates were dissolved, 
the excess CaCl2 came in contact with some SA on adjacent nanostructures which drew the 
nanostructures in a bundle. Appropriate td values affected wall thickness of CaCl2 deposited for 
crosslinking and the characteristics of the gel formed. SEM pictures (Fig. 26) showed that for 
template dipped in 0.1M CaCl2 for N=1 at different values of td, the wall thickness of CaCl2 
deposited increases from 95nm for clean template to 143nm for td=24h. Results are plotted in 
graph (Fig. 27) showing a curve of increasing constant slope which ceases to be linear at around 
td=4h to reach an asymptote. 
 
 
Figure 25. SEM images of nanostructures formed from 1wt% SA crosslinked with 0.1M CaCl2 at N=2 for td=10min 
(right) and td=4h. Results show that at large td, nanostructures formed were distorted and not completely formed 
while at small td, the nanostructures were fully formed nanorods that were stuck in a bundle. 
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Figure 26. SEM images of cross-section (left) and top surface (right) of AAO templates depicting effects of 
infiltration with 0.1M CaCl2 at N=1 and different td values. Average interior diameter of (a) clean AAO template 
pores at 250nm with average wall thickness of 95nm (b) AAO templates dipped in CaCl2 for td=1h at 235nm with 
average wall thickness of 176nm and (c) AAO templates dipped in CaCl2 for td=24h at 143nm with average wall 
thickness of 186nm. 
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Figure 27. Graph of time of dipping td against wall thickness for 0.1M CaCl2. Results show a curve of increasing 
constant slope which ceases to be linear at around td=4h to reach an asymptote 
 
 
 
Similar observations were obtained with the number of times of dipping N. When the templates 
were dipped only once, the gel formed were mechanically weak and collapsed upon drying and 
when templates were dipped three or more times the nanostructures formed either got stuck 
together or flattened towards the surface because they were drawn to the CaCl2 deposited on 
surface (Fig. 28). SEM pictures of deposited CaCl2 on the inner walls at N=1, N=2 and N=10 
revealed that wall thickness increased from clean template thickness at 95nm to 185nm for N=1 
and to 220nm for N=10 approximately (Fig. 29). At N=10, CaCl2 almost completely fills the 
template pores (Fig. 29) showing a trend that tends towards infinity as N is increased. Similarly, 
as N was increased, a thick layer of deposited CaCl2 was formed on the top surface of the 
template thus obstructing further infiltration (Fig. 30). 
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Figure 28. SEM images of nanostructures formed from 1wt% SA crosslinked with 0.1M CaCl2 for td=1h at 
N=1 (left) and N=3 (right). Results show that at low N, the nanostructures formed collapsed due to low 
mechanical strength while at high N, the nanostructures were fully formed but were drawn towards the 
deposited CaCl2 on the surface. 
 
 
 
   
Figure 29. SEM side images of (a) clean template and templates dipped in 0.1M CaCl2 for 10 minutes at (b) 
N=1, (c) N=2 and (d) N=10. Results show that wall thickness increases from clean template thickness at 95nm 
to 185nm for N=1, 220nm for N=10 approximately and infinity at N=10 since CaCl2 almost completely fills the 
template pores. 
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Figure 30. SEM top images of (a) clean template and templates dipped in 0.1M CaCl2 for 10 minutes at (b) 
N=1, (c) N=2 and (d) N=10. Results show that with increasing number of times of dipping N, some 
agglomeration occurs on the top surface and finally a thick layer is deposited preventing further infiltration. 
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8.8 Effect of freeze-drying 
 
To recreate the effect occurring at the nano scale, SA at 2wt% was made to crosslink with 0.1M 
CaCl2 in a drinking straw of 0.6cm in diameter. The gel was crosslinked in a tube-like shape and 
a rod-like shape and left to dry at room temperature and freeze-dried under the same conditions. 
When the piece of rod-like crosslinked gel was left to dry at rtp, the dried gel collapsed under the 
pressure of evaporation (Fig.31). Results showed that when the same rod-like structure was made 
to freeze-dry, the reduced pressure and fast dehydration inhibited the formation of ice crystals so 
as to prevent collapse of the material (Fig. 31). At the nano level, the crosslinked gel in the 
templates needed to be rinsed in DI water several times for freeze-drying to prevent crystals of 
NaOH depositing onto the nanostructures. SEM images for freeze-dried nanostructures resulted in 
inconclusive images since NaOH crystals could not be separated from undissolved templates. 
Until the problem of removing all the NaOH, CaCl2 crystals and undissolved templates, freeze-
dried samples of the nanostructures were useless. In the process of rinsing, some of the 
nanostructures might also have been lost. 
 
Figure 31. Image of 2wt% SA crosslinked with 0.1M CaCl2 in the form of a tube (2 on the left) and rod (2 on the right) and 
left to freeze-dry (left) and at room temperature (right) to examine morphology upon evaporation of water. Results show that 
upon freeze-drying, the gel maintains more of its original shape as compared to the ones left to dry at room temperature 
which collapse. The effect is more pronounced in the case of the tube than for the rod. 
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8.9 Dissolution of template 
 
One major problem observed in the SEM was that despite long dissolution time of the template and 
higher concentration of NaOH solution used, it was impossible to dissolve the template completely. 
Also the SA/CaCl2 that did not crosslink tended to stick to the template preventing contact with the 
NaOH so that chunks of templates remained after dissolution. This in part as mentioned above 
prevented the use of freeze-drying to observe the nanostructures. 
 
8.10 Summary of results 
 
Observations for different trials carried out were summarized in Table 8 below with their 
corresponding SEM pictures given in Appendix A. 
 
 
 
 
Table 8. Summary of observations on the morphology, diameter and length of nanostructures formed based 
on the different variables to be varied namely concentration of SA, td, N and concentration of CaCl2. The 
default conditions were SA at 1 wt%, CaCl2 at 0.1M, td=1h and N=2. 
 
 
 
 
 
 
 
 
 
 
 
Trial No. Morphology length diameter 
A1 0.5%wt No nanostructures n/a n/a 
A2 0.75%wt Bunch of collapsed Nanorods stuck 
together 
10-30  µm 100-300 nm 
A3 1%wt Bunch of nanorods more defined 30-50 µm 100-150 nm 
A4 2%wt Broken dispersed nanorods 5µm 200-300 nm 
B1 10 min Distorted and rods stuck together <4 µm n/a 
B2 1h Fully formed dispersed nanotubes 10-15  µm 200-300nm 
B3 4h Agglomerated nanorods 10-20 µm 100-200 nm 
C1 
C2 
N= 1 Agglomerated nanorods 3-4 µm 200-250 nm 
N=3 Collapsed agglomerated nanotubes 2-3 µm 250-300nm 
D1 
D2 
0.5M Fully formed dispersed nanotubes 3-5  µm 250-280nm 
1M No nanostructures n/a n/a 
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9. FUTURE APPLICATIONS 
 
 
The applications for controlled encapsulated substance carriers responding to a specific stimulus are 
limitless. With the benefits that nanotechnology offers in terms of efficiency, efficacy, cost-
effectiveness and miniaturization, nanostructures engineered with the proper characteristics could be 
used almost everywhere and anywhere. For instance, the most important characteristics of 
crosslinked SA-CaCl2 as nanocarriers are that they can be engineered to be stimuli-responsive and 
that they are non-toxic. The two examples discussed below are just the beginning of the applications 
in which nanocarriers could be used to change lives and the way things will be smartly produced to 
achieve a specific goal. 
 
9.1.  Molecular Gastronomy 
 
Alginates are among the most common material being used extensively in foods for example as 
coagulant and gelling abilities. Renowned chefs like Ferran Adrià who pioneered the technique of 
molecular gastronomy, are currently using alginates to trap fruit juices in spherical shapes to give 
it a caviar-like aesthetic (Fig. 32). Using the same analogy that drugs being delivered would have 
to specific places in the human body at high concentration, similarly, the encapsulated fruit juices 
when delivered on the palate as the alginate skins break would release a concentrated flavor.  
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Figure 32. Picture of esterification of Green Tea. Courtesy of Wikipedia 
 
The mechanism is the same as that of entrapping drugs (Fig. 33). Ultimately, the crosslinked 
SA-CaCl2 gel could be used to encapsulate simple food flavors which can be engineered to as 
to respond to temperature stimuli so that for example the flavors could be released upon 
reaching the temperature of the mouth. The applications of this could also extend to using 
various encapsulated flavors in drinks so as to release a specific flavor at a specific 
temperature. For example, the encapsulated flavor in the SA-CaCl2 could release an apple 
flavor when the drink is heated to a certain temperature and release an orange flavor when 
cooled. The mechanism would be that all the encapsulated flavor that were not freed during 
the stimuli would be washed away through the digestive system since sodium alginate is non-
toxic. 
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Figure 33. Schematic of how the controlled-release encapsulation system works. Nanospheres (blue) 
containing an active ingredient (purple) are encapsulated with other ingredients such as flavors, cooling or 
heating agents, or sweeteners, within a microsphere (yellow). Upon exposure to water or pH, the microsphere 
releases its contents, and over an extended period of time the nanospheres release the encapsulated active 
ingredient via molecular diffusion and enzymatic degradation by lipase. The surface properties of the 
nanospheres (shown as squiggly lines) can be altered to be bioadhesive or negatively or positively charged 
depending on the intended target site 17. 
 
 
 
9.2. Precision Farming 
 
Agriculture is an indispensable economic pillar in most developing countries and more than 60% 
of the population relies on it to live. Using the same loading and release mechanism, improved 
systems could be engineered reducing input (raw materials such as fertilizers, pesticides, 
herbicides etc) through monitoring environmental variables and applying the targeted action 18. 
Precision Farming consists of using global satellite positioning systems and remote sensing 
devices to measure highly localized environmental conditions so as to determine the efficiency at 
which crops are growing 18. Farming processes such as seeding, fertilizer doses and watering can 
thus be fine-tuned to reduce wastage 93. The nanosensors could for example be responsive to the 
pH of the soil or humidity. In the case of crosslinked SA-CaCl2 nanotubes, a substance could be 
enclosed inside the nanostructure so that depending on the pH or humidity, the gel will start to 
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swell and release the substance. The substance in turn will activate a signal that will send the data 
directly via satellite to the central data collection site. 
 
By increasing use of autonomous sensors linked into a GPS system for real-time monitoring, 
these nanosensors could be distributed throughout farm field where they can monitor soil 
conditions and crop growth. Wireless sensors are already being used in certain parts of the USA 
and Australia 18. For example, one of the Californian vineyards, Pickberry, in Sonoma County has 
installed wifi systems with the participation of the IT company, Accenture 94. The initial cost of 
setting up such a system is worth the fact that it enables the best grapes to be grown which helps 
produce finer wines commanded at a premium price. 
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10. CONCLUSIONS 
 
 
The societal benefits of having a more effective drug might help reduce health exposure to side-
effects from drugs and other unforeseeable effects that might possible alter the human gene in more 
serious cases or cause long-term deformations. The potential applications of nanoparticles in the 
medical field are undeniably life-changing as emerging nanosensors, theranostic agents, drug carriers 
and smart stimuli-sensitive multifunctional systems. Among the applications overviewed, this project 
focused on the design of drug carrier system by template-assisted method. It was found that alginates 
are perfect candidates as drug carriers, being non-toxic, biocompatible, easily obtained and relatively 
cheap.   
 
Design of the fabrication technique implied narrowing down the variables. Under the specific 
combination of conditions namely concentration of SA, concentration of CaCl2, number of times of 
dipping and time period of dipping taking into consideration the preparation techniques, well-formed 
nanotubes of 10-15µm and 200-300nm were obtained at 1wt% SA and 0.1M CaCl2. Results under the 
SEM showed that high concentration of SA or CaCl2 tended to increase wall thickness and resulted in 
either filled rods or nanostructures stuck in a bundle. The effects of increasing N and td both also have 
the tendency to cause the nanostructures to be stuck in a bundle while the opposite will result in too 
low strength nanostructures that collapse upon evaporation. The interplay between the various 
variables is a challenge but under the proper combinations will give perfect nanotubes despite the 
problems encountered as undissolved templates, collapse upon drying and non-uniform template 
nanopores. 
 
Despite the low yield of nanostructures obtained, the use of these nanotubes as drug carrier could 
potentially reduce side effects of certain drugs especially vaccines and be more effective in their 
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targeted location. For commercial production, the template-assisted fabrication of these 
nanostructures outlined above offered a viable, direct and cheap alternative. The conditions for the 
template-assisted method are not as critical and confined as compared to other methods of producing 
1D nanostructures.  
 
Successful fabrication of SA-CaCl2 nanostructures can open the doors for future research from the 
established stimuli-responsiveness of these nanotubes. The fact that the crosslinked SA-CaCl2 
nanotubes are capable of self-assembly and are stable in acidic environments confirmed their 
relevance for protecting the drug from gastric acids and as stealth targeting. The underlying driving 
force of using alginates was further motivated by the fact that the SA-CaCl2 nanotubes fabrication did 
not involve any toxic chemicals which will simplify the drug loading process. Future research might 
build up on the pH-swelling response of the gel for loading and unloading of the drug or how to 
enhance this nanostructure in order to prevent leakage of the drug. Since alginates are used in food as 
thickening agents, these nanotubes can also be used for enhanced flavor encapsulation in foods or 
used to encapsulate novel synthetic drink flavors that are liberated depending on different stimuli. 
Alginate micro carriers are already being used in Molecular Gastronomy and could potentially be 
used as nanosensor in Precision Farming. The applications of these nanocarriers are endless and their 
implementation can only be a matter of time as future research builds on substance loading, unloading 
and retention capabilities of these pH-sensitive crosslinked SA-CaCl2 nanostructures. 
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APPENDIX A 
SEM images of trial A2, A3, A4 (pg. 81), B1, B2, B3 (pg. 82), C1, C2 and D1 (pg.83) as outlined in 
Table 8 and given in order of subsequent rows. 
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